Digirad Corporation Board of Directors Appoints R. King Nelson Chairman
January 07 2008 - 7:54PM
PR Newswire (US)
POWAY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Digirad Corporation
(NASDAQ:DRAD), a leading provider of medical diagnostic imaging
products and services to physicians' offices, hospitals and imaging
centers, today announced that its board of directors has appointed
R. King Nelson, a director and member of the audit and governance
committees, chairman of the board effective today. Nelson, 50, has
served on Digirad's board of directors since March 2004. He is
currently president and chief executive officer of Uptake Medical.
From April 2005 to September 2006 he was president and chief
executive officer of Kerberos Proximal Solutions, Inc., a developer
of medical devices used for the treatment of vascular disease. From
May 1999 to December 2003, he was president and chief executive
officer of VenPro Corporation, a medical device company that
develops implants for venous vascular and cardiovascular medicine.
Nelson has more than 18 years of executive-level experience at
Baxter Healthcare Corporation, a health care company, including
serving as president of Baxter's perfusion services business. He
received a Bachelor of Science degree from Texas Tech University
and an MBA degree from the University of Miami. Nelson commented:
"I am pleased to have an opportunity to work with Digirad
management, especially to further extend the reach of their centers
of influence model in the U.S. Based on my experience on both
device and services sides of healthcare, management has initiated a
unique approach to providing key imaging services, services that
address the needs of not only patients but also the physicians who
provide those services, and I look forward to seeing this model
play an increasing role in Digirad's growth and path to
profitability." Nelson replaces Timothy Wollaeger, who resigned as
chairman. He will remain a director but does not intend to stand
for reelection to the board at the Company's annual meeting this
year. Wollaeger was appointed chairman in January 1996 and has been
a director since April 1994. Nelson added, "We owe a great deal to
Tim for helping to bring Digirad to this point and wish him the
very best." About Digirad Corporation Digirad provides diagnostic
medical imaging products and services to physicians' offices,
hospitals and imaging centers for cardiac, vascular, and general
imaging applications. Digirad's Cardius XPO line of nuclear imaging
cameras use patented solid-state technology and unique multi
(single, dual, triple) head design for superior performance and
advanced features for sharper digital images, faster processing,
compact size, lighter weight for portability, ability to handle
patients up to 500 pounds, and improved patient comfort compared to
standard nuclear cameras. Digirad's 2020tc general-purpose nuclear
imager has a small footprint and may also be configured for fixed
or mobile use to supplement primary imaging. Digirad's installed
base of equipment exceeds 450 systems; in addition, a mobile fleet
of more than 120 nuclear and ultrasound imaging systems is being
used in 22 states, primarily in the eastern, midwestern and
southwestern United States. For more information, please visit
http://www.digirad.com/. Digirad(R), Digirad Imaging Solutions(R),
and Cardius(R) are registered trademarks of Digirad Corporation.
Forward-Looking Statements Digirad cautions that statements
included in this press release that are not a description of
historical facts are forward-looking statements. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts and use words such as "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe" and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance or events.
Examples of such statements include statements regarding the
Company's centers of influence business model, benefits of that
business, its role in the Company's growth, and profitability. The
inclusion of these and other forward-looking statements should not
be regarded as a representation by Digirad that any of its plans
will be achieved. Actual results may differ materially from those
set forth in this press release due to the risks and uncertainties
inherent in Digirad's business including, without limitation: the
degree to which personnel changes and related disruptions in our
business activities may affect Digirad's products, customers, work
force, suppliers, and our overall business prospects and
operations; the degree to which Digirad's camera systems and
related services will be accepted by physicians and hospitals some
of whom may experience reliability issues or technical problems;
the ability of Digirad effectively to market, sell and distribute
its medical devices, and related services given its limited
capabilities in these areas; Digirad's ability to manage risks
relating to product liability, warranty claims, recalls, property
damage and personal injury with respect to its imaging systems; and
other risks detailed in Digirad's filings with the U.S. Securities
and Exchange Commission, including its Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, Form 8-K and other reports. Given
these uncertainties, readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date hereof. All forward-looking statements are qualified in
their entirety by this cautionary statement and Digirad undertakes
no obligation to revise or update this press release including the
forward-looking statements contained herein to reflect events or
circumstances after the date hereof or to update the reasons actual
results could differ materially from those anticipated in these
forward-looking statements, even if new information becomes
available in the future. DATASOURCE: Digirad Corporation CONTACT:
Investors, Dan Matsui of Allen & Caron, +1-949-474-4300, , for
Digirad Corporation; or Mark Casner, CEO of Digirad Corporation,
+1-858-726-1600, Web site: http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jul 2024 to Jul 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jul 2023 to Jul 2024